There is experimental evidence suggesting that glucocorticoids may be useful in the prevention of hyaline membrane disease (DeLemos et al., 1970; Kotas et al., 1971) . Large doses of glucocorticoids are, however, well known to cause atrophy of lymphoid tissue and impair brain growth (Howard, 1965; Schapiro, 1965) in immature animals. Thus, before glucocorticoids are used in clinical practice, some consideration must be given to the possible harmful effects of these drugs on the developing organism (Reynolds, 1971) . In addition, it has been suggested (Howard, 1968 ) that repeated stress may interfere with brain growth and cell division through increased adrenocortical secretion and raised plasma corticosteroid levels.
In the work reported here, dexamethasone was administered to developing rats in a single dose (1 mg/kg) comparable with that used clinically in infants, and in a higher dose (20 mg/kg) which has been found necessary to prevent the occurrence of cerebral oedema in asphyxiated immature rats (De Souza and Dobbing, 1973) . Immature rats were also treated daily with cortisol either in a high dose (5 or 50 mg/kg) or in an amount (1 mg/kg) within the range which might be secreted in a stressed infant (Bertrand et al., 1963; Aarskog, 1965;  Alleyne and Young, 1967) .
Rats aged 4 or 5 days were used, since at this age rat brain is at a stage of development comparable with that of the human baby brain towards the latter part of the last trimester of pregnancy (Dobbing, 1970 Zamenhof et al. (1964) .
Results
Dexamethasone at both doses used resulted in an acute reduction in growth of body, brain, and thymus to 7 days of age (Table I) . Thymus was markedly more affected than whole body, while deficits in cerebellar weight were greater than those of the remainder of the brain. The extent of growth retardation in 10-day-old dexamethasonetreated rats, previously reported in preliminary form (Adlard and De Souza, 1973) , was similar to that of 7-day-old animals.
Ultimately, some recovery of growth appeared to occur in animals given the lower dose of dexamethasone (1 mg/kg) since weight deficits at 21 days of age were generally less than those at 7 days (Table I) . However, such recovery was not evident for the high dose (20 mg/kg) of dexamethasone.
Deficits in brain weight in dexamethasonetreated animals at 10 and 21 days of age were associated with greater reductions in total brain ILE II Whole brain DNA in 7-day-old, 10-day-old, and 21-day-old rats after one dose of dexamethasone at 5 days of age Note: Cerebellum was pooled with forebrain and brainstem for these analyses. Results are given as mean ± SD. Each experimental (dexamethasone-treated) animal was paired with a littermate control of the same sex and similar body weight at 5 days of age. There were 3 to 7 pairs (each from a different litter) for each age and dose. Results were compared using the paired comparisons 't' test. All experimental groups showed significant (P <0 05) deficits in brain weight. Mean control wt at 9 dy-mean control wt at 4 dy Differences between experimental (cortisol-treated) and control animals at 9 days of age were compared using Student's 't' test. *P <0 05, tP <0 01, *P <0 001, § not significant.
DNA (Table II) , which were statistically significant except at 21 days in the lower dosed animals. Repeated large daily doses of cortisol impaired growth of body, brain, and thymus (Table III) , though this effect was clearly smaller than with comparable amounts of dexamethasone.
Discussion
The 5-day-old rat brain and the human brain in the perinatal period are in a similar phase of development (Dobbing, 1968 (Dobbing, , 1970 . The adult number of neurons (with few exceptions) have already formed, glial cells have begun to appear, and the establishment of neuronal interconnexions has begun. In the human brain there is still appreciable glial cell formation during the first 18 postnatal months (Dobbing, 1970) . Therefore, any adverse effects of steroid treatment in 4-and 5-day-old rats could, by implication, occur perinatally in human babies.
Deficits in brain weight in rats treated with dexamethasone and those treated with cortisol could be due partly to a reduction in cell numbers, though other developmental processes, including myelination (Howard, 1965) , may also be altered. Other studies suggest that shortly after treatment of animals with cortisol cell mitosis is inhibited in brain (Bala'zs and Cotterrell, 1972) and thymus and lymph nodes (Stevens, Colessides, and Dougherty, 1965) . In the present study cerebellar growth was more retarded than that of the remainder of the brain after glucocorticoid treatment, a type of selectivity also observed after undernutrition (Culley and Lineberger, 1968; Chase, Lindsley, and O'Brien, 1969) and hyperphenylalaninaemia (Chase and O'Brien, 1970) in developing rats. A possible explanation may be found in the very rapid rate of cell formation in the cerebellum during early postnatal life (Dickerson and Dobbing, 1966; Altman, 1970) .
The rate of cortisol secretion is reported to be in the range of 1 * 0 to 1 -5 mg/kg per 24 hr in newbom infants (Aarskog, 1965) and somewhat lower in older children (Bertrand et al., 1963) . Neither body nor brain growth in the suckling rat were significantly affected by cortisol in a dose of 5 mg/kg per 24 hr; thymus growth was reduced at this dose, but not significantly so at 1 mg/kg per 24 hr (Table  III) . If it is reasonable to extrapolate between rat and man it seems likely that increased adrenocortical secretion induced by stress is unlikely to affect brain growth and that any effects on thymus growth would be relatively small.
However, the possible long-term effects of treating pregnant women or newborn babies with glucocorticoids must be considered. Cortisoltreated animals are not only growth retarded, but also show certain behavioural abnormalities (Howard and Granoff, 1968; Schapiro, Salas, and Vukovitch, 1970) . In addition, retarded development of lymphoid tissue could have adverse effects on the body's immune mechanisms.
It can be argued, however, that a direct extrapolation between rat and man is difficult, since human development takes place over a much longer period so that possible adverse effects of steroids are grossly exaggerated when studied in a rapidly growing species such as the rat. There is evidence also that the rat may be more sensitive than man to the thymolytic effects of glucocorticoids (Claman, 1972) . Nevertheless, women who received glucocorticoids in pregnancy are known to have had growth-retarded babies (Warrell and Taylor, 1968 
